UnitedHealth stock closes 1.10% higher on Thursday
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get all exclusive analysis, access our analysis and get Gold and signals alerts
Elevate your trading Journey.
UPGRADEUnitedHealth (UNH) closed at $597.70 on Thursday, 1.10% higher on the day.
UnitedHealth's stock price has increased 13.52% so far this year, less than the 12.64% advance registered by the overall Dow Jones Industrial Average (DJIA) index.
On Thursday, the DJIA fell slightly to close at 42,454.12 points. The three leaders were UnitedHealth (UNH), Salesforce (CRM) and Amazon (AMZN), while the three laggards were Verizon (VZ), Boeing (BA) and Home Depot (HD).
Back to UnitedHealth, its latest earnings report from fiscal Q2 showed that earnings per share (EPS) were at $6.80. Revenue, meanwhile, stood at $98.86 billion.
The next earnings report for UnitedHealth will be published on October 15.
Analysts expect UnitedHealth’s earnings per share to come in at $7.06 for Q3, while revenue is seen at $99.28 billion.
(An automation tool was used in creating this post.)
UnitedHealth (UNH) closed at $597.70 on Thursday, 1.10% higher on the day.
UnitedHealth's stock price has increased 13.52% so far this year, less than the 12.64% advance registered by the overall Dow Jones Industrial Average (DJIA) index.
On Thursday, the DJIA fell slightly to close at 42,454.12 points. The three leaders were UnitedHealth (UNH), Salesforce (CRM) and Amazon (AMZN), while the three laggards were Verizon (VZ), Boeing (BA) and Home Depot (HD).
Back to UnitedHealth, its latest earnings report from fiscal Q2 showed that earnings per share (EPS) were at $6.80. Revenue, meanwhile, stood at $98.86 billion.
The next earnings report for UnitedHealth will be published on October 15.
Analysts expect UnitedHealth’s earnings per share to come in at $7.06 for Q3, while revenue is seen at $99.28 billion.
(An automation tool was used in creating this post.)
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.